Ballentine Partners »

Theravance Biopharma shares owned by Ballentine Partners

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Ballentine Partners from 13F filings

Historical chart of Ballentine Partners investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Ballentine Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Ballentine Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $104k 13k 8.06

More positions owned by Ballentine Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Core Msci Emkt (IEMG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Etf (IWB)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Ballentine Partners

Top funds holding Theravance Biopharma

Weiss Asset Management LP[1
Newtyn Management
BlackRock
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
State Street Corporation
Geode Capital Management
D. E. Shaw & Co
Pictet Asset Management Holding SA
Jacobs Levy Equity Management
Bank of America Corporation
Morgan Stanley
Dimensional Fund Advisors

View all funds holding Theravance Biopharma